Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Chinese Medicine
  4. Vol 7, Issue 3, 2025

Study on TCM Stepwise Intervention Strategy for Amyotrophic Lateral Sclerosis Based on the Progressive Theory of "Zongqi - Weiqi - Yuanqi": Integration of Clinical Evidence and Mechanism Discussion

Download as PDF

DOI: 10.23977/medcm.2025.070306 | Downloads: 1 | Views: 107

Author(s)

Yan Tian 1, Bingcang Yan 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Xi'an Traditional Chinese Medicine Encephalopathy Hospital, Xi'an, Shaanxi, 710068, China

Corresponding Author

Bingcang Yan

ABSTRACT

This study investigates a Traditional Chinese Medicine (TCM) stepwise intervention strategy for amyotrophic lateral sclerosis (ALS) based on the progressive theory of "Zongqi–Weiqi–Yuanqi." Literature from the past 15 years was systematically reviewed to reconstruct disease evolution and evaluate therapeutic efficacy. In the early stage, Zongqi collapse is characterized by abnormal respiratory muscle function (87.9%), which precedes measurable pulmonary impairment (52.3%). In the middle stage, Weiqi dysfunction arises. The spleen–lung invigorating method reduces ALSFRS-R monthly decline to 0.64–0.66 points by inhibiting p38 MAPK phosphorylation and suppressing inflammatory cascades. In advanced stages, Yuanqi decline dominates, and spleen–kidney tonification protects neurons via activation of PINK1/Parkin-mediated mitophagy. Internal–external combined therapy further improves outcomes, increasing the total effective rate to 88.46%. Based on these findings, a stepwise framework—“cultivating Zongqi, consolidating Weiqi, and preserving Yuanqi”—is proposed to align therapeutic strategies with disease progression. This model provides a systematic explanation of ALS pathogenesis and offers a structured clinical pathway for precision TCM treatment.

KEYWORDS

Amyotrophic Lateral Sclerosis; Zongqi; Weiqi; Yuanqi; Lung - Spleen Theory; Spleen - Kidney Theory; Stepwise Intervention; Traditional Chinese Medicine

CITE THIS PAPER

Yan Tian, Bingcang Yan, Study on TCM Stepwise Intervention Strategy for Amyotrophic Lateral Sclerosis Based on the Progressive Theory of "Zongqi - Weiqi - Yuanqi": Integration of Clinical Evidence and Mechanism Discussion. MEDS Chinese Medicine (2025) Vol. 7: 37-41. DOI: http://dx.doi.org/10.23977/medcm.2025.070306.

REFERENCES

[1] Luo XH, Du BX, Zheng Y, Lu M, Wang AQ. Clinical efficacy of Lung-Spleen theory in treating amyotrophic lateral sclerosis. Chinese Journal of Gerontology. 2016;36(09):2219-2221. 
[2] Hong YM, Wu SB, Du BX, Zheng Y, Yang BY, Zhou MJ, et al. Clinical study of pulmonary function and respiratory muscle function in patients with amyotrophic lateral sclerosis. Journal of Clinical Neurology. 2016;29(04):267-269. 
[3] Zhou MJ, Zheng Y, Du BX, Xu YJ. Characteristics of pulmonary function and respiratory muscle function in patients with amyotrophic lateral sclerosis. Guangdong Medical Journal. 2010;31(24):3209-3211. 
[4] Liu CM, Meng FH. Misdiagnosis of amyotrophic lateral sclerosis as pulmonary infection: A report of 2 cases. Shandong Medical Journal. 1995;(04):55. 
[5] Zheng Y, Zhou W, Yang BY, Wang AQ, Xu HY, Hou XM, et al. Effects of Lung-Spleen treatment on muscle strength and respiratory function in amyotrophic lateral sclerosis. Liaoning Journal of Traditional Chinese Medicine. 2016;43(08):1676-1677. 
[6] Zheng Y, Ren ZN, Wang AQ, Hou XM, Lu M, Du BX. Efficacy observation of Lung-Spleen treatment on motor function and quality of life in amyotrophic lateral sclerosis. Lishizhen Medicine and Materia Medica Research. 2016;27(02):391-392. 
[7] Pan XM, Yang BY, Du BX, Zheng Y, Li HZ. Effects of "Jianpi Yifei" decoction on spinal cord p38 MAPK protein and inflammatory factor expression in hSOD1-G93A transgenic mice with amyotrophic lateral sclerosis. Chinese Journal of Experimental Traditional Medical Formulae. 2018;24(15):155-160. 
[8] Wu FF, Li TT, Tang HY, Jing W, Shan YT, Wei SY, Pan WD. Diagnosis and treatment of amyotrophic lateral sclerosis with integrated internal-external approaches based on TCM spleen-kidney theory. Journal of Neurology and Neurorehabilitation. 2024;20(03):92-97. 
[9] Zhu W, Wang MZ, Li TT, Liu Y, Pan WD. Mechanistic study of "Jianpi Bushen" decoction in treating amyotrophic lateral sclerosis. Journal of Neurology and Neurorehabilitation. 2021;17(02):57-62. 
[10] Gu JX, Jiang YW, Gu XZ. Professor Gu Xizhen's experience in treating amyotrophic lateral sclerosis from spleen-kidney theory. Tianjin Journal of Traditional Chinese Medicine. 2020;37(04):438-441. 
[11] Liao WL, Jiang WF, Gao PL, Yuan YK, Gui LQ, Pan WD. Treatment of amyotrophic lateral sclerosis from spleen theory based on TCM basic theory. Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease. 2019;17(07):1029-1031. 
[12] Li P. Effects of "Jianpi Yifei" decoction combined with massage on neurological function and electromyography in patients with amyotrophic lateral sclerosis. Sichuan Journal of Traditional Chinese Medicine. 2019;37(08):147-149. 
[13] Li YQ, Luo LN, Shen JQ. Efficacy observation of acupoint application combined with "Jianpi Yifei" decoction in treating amyotrophic lateral sclerosis. Liaoning Journal of Traditional Chinese Medicine. 2022;49(05):169-172. 
[14] Zhong HL, Lu M, Xu HY, Du BX, Zheng Y, Ding MZ. Ventilator combined with "Jianpi Yifei" decoction in treating 9 cases of amyotrophic lateral sclerosis complicated with respiratory failure. Journal of Traditional Chinese Medicine. 2013;54(11):939-941. 
[15] Xu H, Qin LF, Qiu T, Qiu C. Clinical observation of Du Meridian moxibustion in treating 22 cases of spleen-kidney yang deficiency type amyotrophic lateral sclerosis. Journal of Traditional Chinese Medicine. 2024;65(17):1802-1807. 

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 8493
Visits: 470725

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.